SEC Form 4 · accession 0000899243-15-010245
ZS Pharma, Inc. · ZSPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Marc Ostro
Director
Period of report
Dec 17, 2015
Accepted (ET)
Dec 21, 2015 · 8:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001459266
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 17, 2015 | D | 1,000 | $90.00 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (NQ) - 8/22/14 | $32.56 | Dec 17, 2015 | D | 12,000 | D | Aug 22, 2015 | Aug 21, 2024 | Common Stock | 12,000 | 0 | D |
| Stock Options (NQ) - BOD 6/18/15 | $55.57 | Dec 17, 2015 | D | 4,000 | D | Jun 18, 2016 | Jun 17, 2025 | Common Stock | 4,000 | 0 | D |
Explanation of responses
- F1Includes 1,000 shares in the form of restricted stock units